KLRK1 and neoplasm: Small molecule EZH2 inhibition can simultaneously up-regulate NKG2D ligand on tumor cells, indicating that EZH2i can enhance NK killing by simultaneously regulating important NK activation molecules on NK cells and tumor cells (Fig. 4D).